The Institute of Ageing and Chronic Disease is proud to support a range of public outreach and engagement activities. We believe that ensuring that our research is accessible to those outside of our Institute is beneficial, not just for those able to learn about our work, but in guiding the focus of our research, ensuring that we are constantly referencing real-world problems when applying strategies and exploring new avenues of research.
To do this we explore a range of opportunities allowing us to engage with the public and those who may be affected by our research, as well as schools and colleges, helping to ensure that the next generation of scientists has an opportunity to explore the possibilities available to them.
Patient Involvement Panel
The Institute of Ageing and Chronic Disease Musculoskeletal Biology Patient Involvement Panel (PIP) was established in 2017. Chaired by Dr Helen Wright, the panel serves as a resource for our researchers to engage directly with patients who may be living with the conditions which they are investigating, helping to shape the direction of our research strategy and ensure that they remain focused on delivering research with a real-world benefit. The events also afford patients the opportunity to hear presentations from our researchers, as well as invited external speakers from clinical and scientific backgrounds, giving them an insight into the most up to date advancements in the field of musculoskeletal ageing and chronic disease
Meetings are held 3 times a year with the aim of:
- Providing a new pair of eyes for research ideas
- Helping researchers to write lay summaries
- Reviewing applications to funders that require public involvement
- Helping researchers present their research in an easy to understand manner
Our panel is made up of around 10 patient insight partners who together have personal or family experience of a wide range of musculoskeletal conditions, including: Osteoarthritis, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Vasculitis, Systemic Lupus, Erythematosus Behçets Disease, and Myositis Fibromyalgia.